![]() |
VRNA | Verona Pharma Plc |
Pharmaceutical Preparations |
Book value per $ invested | $ 0.02 |
Leverage | 56.88% |
Market Cap | $ 41.5B |
PE | 0.00 |
Dividend Yield | 0.00% |
Profit | $ -163.6m |
Margin | -211.67% |
Verona Pharma plc, a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company is headquartered in London, the United Kingdom.